Intermediate ATXN2 repeats were found in C9orf72 expansion carriers both in ALS and ALS/FTD patients, but absent in FTD, suggesting that ATXN2 CAG expansion might act as a disease modifier towards ALS of the ALS/FTD spectrum [26]. Here, C9orf72 is linked to frontotemporal dementia.